Sign in
4

Changes in Ownership

Faeth Therapeutics, Inc. Filed Acc 0001567619-22-005913

10% owner bought 2,500 shares at $3.60 ($9,000)

From the SEC's structured data for this filing

Trades in this filing

Cambrian BioPharma Inc · 10% owner

Table I: Non-derivative

2 lines
Date Transaction Shares Price Value Owned after D/I
2022-02-28 Purchase : show line 1 in the form +42 $3.60 $151 5,228,328 D
2022-03-01 Purchase : show line 2 in the form +2,458 $3.60 $8,849 5,230,786 D
Open-market purchases · 2,500 sh · avg $3.60 · $9,000
Loading xslF345X03/doc1.xml…